Kenvue Inc. (KVUE)

KVUE Income Statement

Revenue, expenses, and profitability analysis

KVUE Quarterly Income Statement (USD)

Quarterly Report	TTM	03/29/2026	12/28/2025	09/28/2025	06/29/2025	03/30/2025	12/31/2024	09/29/2024	06/30/2024
Revenue	15.292B	3.909B	3.780B	3.764B	3.839B	3.741B	3.662B	3.899B	4.000B
Cost of Goods Sold	6.366B	1.607B	1.643B	1.538B	1.578B	1.573B	1.592B	1.617B	1.635B
Gross Profit	8.926B	2.302B	2.137B	2.226B	2.261B	2.168B	2.070B	2.282B	2.365B
Gross Profit Margin	58.9%	58.9%	56.5%	59.1%	58.9%	58.0%	56.5%	58.5%	59.1%
Total Operating Expenses	5.931B	1.453B	1.312B	1.597B	1.569B	1.610B	1.587B	1.628B	2.211B
Research & Development	84.000M	84.000M	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	6.004B	1.453B	1.535B	1.512B	1.504B	1.537B	1.525B	1.590B	1.641B
Operating Income (EBIT)	3.001B	855.000M	825.000M	629.000M	692.000M	558.000M	483.000M	654.000M	154.000M
Operating Margin	21.9%	21.9%	21.8%	16.7%	18.0%	14.9%	13.2%	16.8%	3.9%
Income Before Tax (EBT)	2.213B	672.000M	427.000M	526.000M	588.000M	458.000M	346.000M	577.000M	65.000M
Interest Income	13.000M	—	—	—	13.000M	13.000M	—	—	14.000M
Interest Expense	393.000M	95.000M	98.000M	93.000M	107.000M	107.000M	148.000M	96.000M	106.000M
Other Income/Expense	-788.000M	-183.000M	-398.000M	-103.000M	-104.000M	-100.000M	-137.000M	-77.000M	-89.000M
Net Income	1.622B	474.000M	330.000M	398.000M	420.000M	322.000M	293.000M	383.000M	58.000M
Income Tax Expense	591.000M	198.000M	97.000M	128.000M	168.000M	136.000M	53.000M	194.000M	7.000M
Net Profit Margin	12.1%	12.1%	8.7%	10.6%	10.9%	8.6%	8.0%	9.8%	1.5%
EBITDA	3.170B	910.000M	663.000M	760.000M	837.000M	701.000M	644.000M	855.000M	312.000M
EBITDA Margin	23.3%	23.3%	17.5%	20.2%	21.8%	18.7%	17.6%	21.9%	7.8%
Depreciation & Amortization	564.000M	143.000M	138.000M	141.000M	142.000M	136.000M	150.000M	182.000M	141.000M
EPS Basic	0.85	0.25	0.17	0.21	0.22	0.17	0.15	0.20	0.03
EPS Diluted	0.85	0.25	0.17	0.21	0.22	0.17	0.15	0.20	0.03
Shares Outstanding	1.918B	1.918B	1.916B	1.918B	1.917B	1.914B	1.916B	1.915B	1.915B
Diluted Shares Outstanding	1.922B	1.922B	1.920B	1.923B	1.927B	1.925B	1.929B	1.924B	1.920B

KVUE Annual Income Statement (USD)

Annual Report	12/28/2025	12/29/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	15.124B	15.455B	15.444B	14.950B	15.054B	14.467B	14.324B
Cost of Goods Sold	6.332B	6.496B	6.801B	6.665B	6.635B	6.619B	6.662B
Gross Profit	8.792B	8.959B	8.643B	8.285B	8.419B	7.848B	7.662B
Gross Profit Margin	58.1%	58.0%	56.0%	55.4%	55.9%	54.2%	53.5%
Total Operating Expenses	6.088B	7.118B	6.131B	5.610B	5.499B	8.827B	5.816B
Research & Development	382.000M	0.00	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	6.088B	6.027B	6.141B	5.633B	5.484B	4.956B	5.198B
Operating Income (EBIT)	2.704B	1.841B	2.512B	2.675B	2.920B	-979.000M	1.846B
Operating Margin	17.9%	11.9%	16.3%	17.9%	19.4%	-6.8%	12.9%
Income Before Tax (EBT)	1.999B	1.415B	2.190B	2.637B	2.925B	-1.016B	2.120B
Interest Income	—	53.000M	108.000M	—	—	—	—
Interest Expense	379.000M	431.000M	358.000M	—	—	—	—
Other Income/Expense	-705.000M	-426.000M	-322.000M	-38.000M	5.000M	-37.000M	274.000M
Net Income	1.470B	1.030B	1.664B	2.064B	2.078B	-879.000M	1.435B
Income Tax Expense	529.000M	385.000M	526.000M	573.000M	847.000M	-137.000M	685.000M
Net Profit Margin	9.7%	6.7%	10.8%	13.8%	13.8%	-6.1%	10.0%
EBITDA	2.935B	2.468B	3.175B	3.281B	3.656B	3.734B	3.108B
EBITDA Margin	19.4%	16.0%	20.6%	21.9%	24.3%	25.8%	21.7%
Depreciation & Amortization	557.000M	622.000M	627.000M	644.000M	731.000M	746.000M	709.000M
EPS Basic	0.77	0.54	0.90	1.08	1.10	-0.47	0.76
EPS Diluted	0.76	0.54	0.87	1.08	1.10	-0.47	0.76
Shares Outstanding	1.917B	1.915B	1.849B	1.915B	1.889B	1.889B	1.889B
Diluted Shares Outstanding	1.924B	1.923B	1.915B	1.915B	1.889B	1.889B	1.889B

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Summit, NJ

22,000 employees

www.kenvue.com

Consumer Defensive / Household & Personal Products

Sector: Consumer Defensive
Industry: Household & Personal Products
CEO: Kirk L. Perry

View full financials